2023-2024
| Graduate Name | Dissertation Title | Advisor | First Position after Graduation |
|---|---|---|---|
| Rupal Aroza | "Secular trends and determinants of use of gabapentin during pregnancy among publicly insured pregnant persons in the United States 2000 to 2015" | Dr. Almut Winterstein | Ph.D. student in the University of Kentucky College of Pharmacy |
| Sebastian Jugl | Dr. Almut Winterstein | UF Ph.D. Graduate Program in POP | |
| Wenxi Huang | Trajectories of Sacubitril/Valsartan Adherence among Medicare Beneficiaries with Heart Failure | Dr. Serena Guo | UF Ph.D. Graduate Program in POP |
2022-2023
| Graduate Name | Dissertation Title | Advisor | First Position after Graduation |
|---|---|---|---|
| Dawei Guan | "Individualized cost-effectiveness assessment of sodium-glucose cotransporter 2 inhibitors versus sulfonylureas as add-on therapy in people with inadequately controlled type 2 diabetes under metformin monotherapy." | Dr. Hui Shao | UF Ph.D. Graduate Program in POP |
| Khalid Alkhuzam | "Long-Term Health Benefit and Economic Return of Time in Range (TIR) Improvement in Individuals with Type 2 Diabetes" | Dr. Hui Shao | |
| Alaa Alshehri | "Racial/Ethnic and Socioeconomic Disparities in the Utilization of GLP-1Ra and SGLT2i among US Adults with Type 2 Diabetes by Cardiovascular and Renal Disease Indications (2018-2019)" | Dr. Hui Shao | UF Ph.D. Graduate Program in POP |
| Wei-Han (William) Chen | "Geographic Variation and Racial Disparities in Newer Glucose-Lowering Drugs Adoption among US Medicare Beneficiaries with Type 2 Diabetes" | Dr. Serena Guo | UF Ph.D. Graduate Program in POP |
| Shu Niu | "5-Year Simulation of Diabetes-Related Complications in People Treated with Tirzepatide or Semaglutide Vs. Insulin Glargine" | Dr. Serena Guo | UF Ph.D. Graduate Program in POP |
2020 – 2021
| Graduate | Thesis Title | Advisor | First Position After Graduation |
|---|---|---|---|
| Yahan Zhang | "Association Between Social Determinates of Health and Risk of Type 2 Diabetes in Adults Aged 18-45 " | Dr. Hui Shao | Ph.D. program, University of Texas at Austin |
| Aimalohi Rosemary Okpeku | 30-Day Cause Hospital Readmission Risk among People Living with HIV by Mental Health Condition and Substance Use Disorder Status | Dr. Amie Goodin | Virginia Commonwealth University |
| Shailina Keshwani | Buprenorphine Use Trends Following Prior Authorization Policy Change for the Treatment of Opioid Use Disorder in the State Medicaid Programs, From 2013 To 2020 | Dr. Juan Hincapie -Castillo | Ph.D. Program, Department of Pharmaceutical Outcomes and Policy, University of Florida |
| Golnoosh Alipour Haris | Medication regimen complexity among Medicare beneficiaries newly diagnosed with Alzheimer's Disease and Related Dementias | Dr. Joshua Brown | Ph.D. Program, Department of Pharmaceutical Outcomes and Policy, University of Florida |
2019-2020
| Graduate | Thesis Title | Advisor | First position after graduation |
|---|---|---|---|
| Mashael Alaskar | “Evaluation of the Use of Loop Diuretics Following Fluid Resuscitation In Intensive Care Unit Septic Patients” | Dr. Scott Vouri | Quality & Safety Specialist, King Faisal Specialist Hospital & Research Center, Saudi Arabia. |
| Abdulrahman Alsuhibani | Statins Use Following "Bariatric Surgery: Factors Associated with the Discontinuation" | Dr. Scott Vouri | Ph.D. program, University of Cincinnati |
| Fatimah Alyami | Dr. Vakaramo Diaby | Ph.D. program, University of Cincinnati | |
| Ching-Yu Wang | "Predicting the Cost-Effectiveness of Generic versus Brand Dabigatran Using Pharmacometric Estimates among Patients with Atrial Fibrillation" | Dr. Joshua Brown | Ph.D. Program, Department of Pharmaceutical Outcomes and Policy, University of Florida |
2017-2018
| Gradaute | Thesis Title | Advisor | First position after graduate |
|---|---|---|---|
| Juan Hincapie-Castillo, Pharm.D. | "Prevalence of Psychotherapy Surrounding Initiation of Psychotropic Polypharmacy in the Medicaid-Insured Population, 1999-2010" | Dr. Almut Winterstein | Ph.D. student, Department of Pharmaceutical Outcomes and Policy, University of Florida |
| Ghadeer Dawwas, B.S.Pharm., M.B.A. | "Cardiovascular Safety of Sodium Glucose Co-Transporter-2 Inhibitors in Patients with Type II Diabetes" | Dr. Haesuk Park | Ph.D. student, Department of Pharmaceutical Outcomes and Policy, University of Florida |
| Yoon Young Choi, B.S.Pharm., M.S. | "A Dynamic Risk Model for Inpatient Falls: Are They Predictable?" | Dr. Almut Winterstein | Ph.D. student, Department of Pharmaceutical Outcomes and Policy, University of Florida |
| Abdullah Alalwan, Pharm.D., Ph.D. | "Trends in the Utilization of Warfarin and Direct Oral Anticoagulants in Older Adult Patients with Atrial Fibrillation" | Dr. Haesuk Park | Ph.D. student, Department of Pharmaceutical Outcomes and Policy, University of Florida |
| Sascha van Boemmel-Wegmann, B.S.Pharm. | "Treatment initiation and Drug Cost Burden of Hepatitis C (HCV) Therapies among HCV Patients in the United States with a Particular Focus on the HIV Co-Infected Population" | Dr. Haesuk Park | Ph.D. student, Department of Pharmaceutical Outcomes and Policy, University of Florida |
| Chintal Shah, M.S. | "Factors affecting adherence to hormonal therapy in breast cancer patients" | Dr. Hong Xiao | Ph.D. student, University of Maryland, Department of Pharmaceutical Health Services Research |
| Yue Cheng, M.S. | "The association between healthcare utilization and physical functioning in older adults" | Dr. Joshua Brown | Ph.D. student, University of Kentucky, Department of Pharmaceutical Outcomes and Policy |
| Omotola Olasupo, M.S. | "Missed opportunities for influenza and pneumococcal vaccinations in adults in the United States" | Dr. Joshua Brown | |
| Ziyan Chen, M.S. | "A value-based pricing study on inotuzumab ozogamicin for B-cell precursor acute lymphoblastic leukemia (B-cell All) in the United States" | Dr. Vakaramoko Diaby | Ph.D. student, University of Florida, Department of Pharmaceutical Outcomes and Policy |
| Ming Chen, M.S. | "Variation in quality of care in use of vena cava filters for hospitalized venous thromboembolism patients" | Dr. Joshua Brown | |
| Chao Chen, M.S. | Dr. Abraham Hartzema | Ph.D. Program, Department of Pharmaceutical Outcomes and Policy, University of Florida | |
| Yanmim Zhu, M.S. | Dr. Almut Winterstein | Ph.D. Program, Department of Pharmaceutical Outcomes and Policy, University of Florida |
2016-2017
| Graduate | Thesis Title | Advisor | First position after graduation |
|---|---|---|---|
| Xinyi Jiang, B.S. | "Trends in readmission rates, hospital charges and mortality for patients with chronic obstructive pulmonary disease (COPD) in Florida from 2009 to 2014" | Dr. Haesuk Park | Ph.D. student, department of pharmaceutical outcomes and policy, University of Florida |
| Hend Mansoor, Pharm.D., M.S. | Dr. Richard Segal |
2014-2015
| Graduate | Advisor | First position after graduation |
|---|---|---|
| Justin Doan, M.P.H., M.S. | Dr. Abraham Hartzema | Associate Director - Oncology, Bristol-Myers Squibb |
| Rishi Ramkissoon | Dr. Richard Segal | Manager CVS/Caremark, Specialty Pharmacy |
| Donna Rivera, Pharm.D., M.S. | Dr. Abraham Hartzema | Program Director, Clinical and Translational Epidemiology Branch, National Cancer Institute |
2011-2012
| Graduate | Advisor | First position after graduation |
|---|---|---|
| Steven T. Bird | Dr. Almut Winterstein / Dr. Abraham Hartzema | Commissioned Officer with FDA |
| Brian Burford | Dr. David Brushwood | Pharmacist/Healthcare Leader Greater Memphis Area AnovoRx VP, Specialty Pharmacy Programs |
| Lyle J. Canida | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Evelyn N. Hong | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Amy N. Houtchens | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Jean M. Lester | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Monica A. Munoz | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Salvatore R. Pepe | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Hanah Pham | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Jessica Voqui | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Hong Hanh Vu | Dr. Almut Winterstein | Commissioned Officer with FDA |
2010-2011
| Graduate | Advisor | First position after graduation |
|---|---|---|
| Bingcao Wu, B.S., M.S. | Dr. Richard Segal | Research Analyst, HealthCore, Inc., Wilmington, DE |
| David A. Folmar | Dr. Richard Segal | Commissioned Officer with FDA |
| Matthew C. Kirchoff | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Jonas P. Santiago | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Danielle Janine Smith | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Jame P. Trinidad | Dr. Almut Winterstein | Commissioned Officer with FDA |
| Evan B. Wearne | Dr. Almut Winterstein | Commissioned Officer with FDA |
Graduates before 2010
| Graduate | Advisor | First position after graduation |
|---|---|---|
| Jae-Min Hwang, B.S., M.S. | Dr. Richard Segal | |
| Lek Rungreangyingyod, B.S., M.S. | Dr. Earlene Lipowski | Enrolled into a Ph.D. program at a different university |
| Karen Mitchell, B.S., M.S. | Dr. Earlene Lipowski | Pharmaceutical Analyst, Mercer Consulting, New York, NY |
| Harry Nyanteh, M.D., M.S.C., M.P.H. | Dr. Richard Segal | Clinical Trials Coordinator, InterCare DX, Hawthorne, CA |
| Dora Mouallem, B.S., M.S. | Dr. Richard Segal | Returned to home country to work as a pharmacist |
| Mark Monteath, B.S., B.A., M.S. | Dr. Earlene Lipowski | Field representative, AstraZeneca (Southeastern quadrant, United States) |
| William Garst, B.S., M.P.H., M.S. | Dr. L. Douglas Ried | Pharmacy Department, Shands at Alachua General Hospital, Gainesville, FL |
| Matt Morrow, B.S., M.S. | Dr. L. Douglas Ried | Pharmacy Department, VA Medical Center, Gainesville, FL |
| Clarence McMillan, Pharm.D., M.S. | Dr. Earlene Lipowski |
